synthalin A

Known as: bisG10, 1,10-decamethylenediguanide, 1,10-bis(guanidino)-n-decane 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1954-2007
01219542007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
OBJECTIVES Emergence of multidrug-resistant bacteria has encouraged vigorous efforts to develop antimicrobial agents with new… (More)
  • figure 1
  • table 1
  • table 3
Is this relevant?
1995
1995
The effects of a K+ channel blocker, bisG10, were examined on ATP-sensitive K+ (KATP) channels in membrane patches excised from… (More)
Is this relevant?
1992
1992
The action of bisG10, a potent K+ channel inhibitor, was tested on the Ca2+ release from isolated sarcoplasmic reticulum vesicles… (More)
Is this relevant?
1989
1989
The role of K+ as a counterion during Ca2+ release from the sarcoplasmic reticulum (SR) has been investigated. An optical… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table I
Is this relevant?
1983
1983
Synthalin A is a guanidine derivative, chemically related to the antidiabetic drugs of the biguanide group. The effects of this… (More)
Is this relevant?
Review
1958
Review
1958
In a number of studies it has been repeatedly suggested that the alpha cells of the pancreatic islet would be responsible for the… (More)
Is this relevant?
1956
1956
In spite of the amount of work done on origin of glucagon, there is no agreement as to the site of its production (1-5). Some… (More)
Is this relevant?